🇺🇸 FDA
Pipeline program

VGX 3100

HPV-003

Phase 2 mab completed

Quick answer

VGX 3100 for Cervical Intraepithelial Neoplasia is a Phase 2 program (mab) at INOVIO PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
INOVIO PHARMACEUTICALS, INC.
Indication
Cervical Intraepithelial Neoplasia
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials